Uropathogenic Escherichia coli express type 1 fimbriae only in surface adherent populations under physiological growth conditions

Journal of Infectious Diseases

Volumn 213, Issue 3, 2016, Pages 386-394

  Stærk, Kristian ^a,b   Khandige, Surabhi ^a   Kolmos, Hans Jørn ^a,b   Møller Jensen, Jakob ^a   Andersen, Thomas Emil ^a,b  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

biofilm; catheter associated infection; E. coli UTI89; type 1 fimbriae; urinary tract infection; uropathogenic E. coli

Indexed keywords

FIMBRIA PROTEIN; TYPE 1 FIMBRIAE PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BIOFILM; BLADDER; CELL ADHESION; CELL AGGLUTINATION; CELL INVASION; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STRAIN IDENTIFICATION; UROPATHOGENIC ESCHERICHIA COLI; BACTERIUM ADHERENCE; BLADDER TUMOR; CARCINOMA; CLASSIFICATION; FIMBRIA; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MICROBIOLOGY; PHYSIOLOGY; SACCHAROMYCES CEREVISIAE; TUMOR CELL LINE;

BACTERIAL ADHESION; CARCINOMA; CELL LINE, TUMOR; FIMBRIAE, BACTERIAL; GENE EXPRESSION REGULATION, BACTERIAL; HUMANS; SACCHAROMYCES CEREVISIAE; URINARY BLADDER NEOPLASMS; UROPATHOGENIC ESCHERICHIA COLI;

EID: 84960398765     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiv422     Document Type: Article

References (52)

1. Stamm WE, Norrby SR. Urinary tract infections: disease panorama and challenges. J Infect Dis 2001; 183: S1-4.
2. Foxman B. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Am J Med 2002; 113: 5-13.
3. Foxman B. Urinary tract infection syndromes: occurrence, recurrence, bacteriology, risk factors, and disease burden. Infect Dis Clin North Am 2014; 28: 1-13.
4. Ronald A. The etiology of urinary tract infection: traditional and emerging pathogens. Dis Mon 2003; 49: 71-82.
5. Nielubowicz GR, Mobley HL. Host-pathogen interactions in urinary tract infection. Nat Rev Urol 2010; 7: 430-41.
6. Sivick KE, Mobley HL. Waging war against uropathogenic Escherichia coli: winning back the urinary tract. Infect Immun 2010; 78: 568-85.
7. Ulett GC, Totsika M, Schaale K, Carey AJ, Sweet MJ, Schembri MA. Uropathogenic Escherichia coli virulence and innate immune responses during urinary tract infection. Curr Opin Microbiol 2013; 16: 100-7.
8. Flores-Mireles AL, Walker JN, Caparon M, Hultgren SJ. Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nat Rev Microbiol 2015; 13: 269-84.
9. Mysorekar IU, Hultgren SJ. Mechanisms of uropathogenic Escherichia coli persistence and eradication from the urinary tract. Proc Natl Acad Sci U S A 2006; 103: 14170-5.
10. Kerrn MB, Struve C, Blom J, Frimodt-Møller N, Krogfelt KA. Intracellular persistence of Escherichia coli in urinary bladders from mecillinam-treated mice. J Antimicrob Chemother 2005; 55: 383-6.
11. Blango MG, Mulvey MA. Persistence of uropathogenic Escherichia coli in the face of multiple antibiotics. Antimicrob Agents Chemother 2010; 54: 1855-63.
12. Connell I, AgaceW, Klemm P, Schembri M, Mãrild S, Svanborg C. Type 1 fimbrial expression enhances Escherichia coli virulence for the urinary tract. Proc Natl Acad Sci U S A 1996; 93: 9827-32.
13. Wright KJ, Seed PC, Hultgren SJ. Development of intracellular bacterial communities of uropathogenic Escherichia coli depends on type 1 pili. Cell Microbiol 2007; 9: 2230-41.
14. Roos V, Nielsen EM, Klemm P. Asymptomatic bacteriuria Escherichia coli strains: adhesins, growth and competition. FEMS Microbiol Lett 2006; 262: 22-30.
15. Reisner A, Maierl M, Jörger M,. et al. Type 1 fimbriae contribute to catheter-Associated urinary tract infections caused by Escherichia coli. J Bacteriol 2014; 196: 931-9.
16. Lim JK, Gunther NW 4th, Zhao H, Johnson DE, Keay SK, Mobley HLT. In vivo phase variation of Escherichia coli type 1 fimbrial genes in women with urinary tract infection. Infect Immun 1998; 66: 3303-10.
17. Abraham JM, Freitag CS, Clements JR, Eisenstein BI. An invertible element of DNA controls phase variation of type 1 fimbriae of Escherichia coli. Proc Natl Acad Sci U S A 1985; 82: 5724-7.
18. Klemm P. Two regulatory fim genes, fimB and fimE, control the phase variation of type 1 fimbriae in Escherichia coli. EMBO J 1986; 5: 1389-93.
19. Hagan EC, Lloyd AL, Rasko DA, Faeber GJ, Mobley HL. Escherichia coli global gene expression in urine from women with urinary tract infection. PLoS Pathog 2010; 6: e1001187.
20. Schwan WR. Regulation of fim genes in uropathogenic Escherichia coli. World J Clin Infect Dis 2011; 1: 17-25.
21. Gally DL, Bogan JA, Eisenstein BI, Blomfield IC. Environmental regulation of the fim switch controlling type 1 fimbrial phase variation in Escherichia coli K-12: effects of temperature and media. J Bacteriol 1993; 175: 6186-93.
22. Olsen PB, Schembri MA, Gally DL, Klemm P. Differential temperature modulation H-NS of the fimB and fimE recombinase genes which control the orientation of the type 1 fimbrial phase switch. FEMS Microbiol Lett 1998; 162: 17-23.
23. Stahlhut SG, Struve C, Krogfelt KA, Reisner A. Biofilm formation of Klebsiella pneumoniae on urethral catheters requires either type 1 or type 3 fimbriae. FEMS Immunol Med Microbiol 2012; 65: 350-9.
24. Mulvey MA, Schilling JD, Hultgren SJ. Establishment of a persistent Escherichia coli reservoir during the acute phase of a bladder infection. Infect Immun 2001; 69: 4572-9.
25. Andersen TE, Khandige S, Madelung M, Brewer J, Kolmos HJ, Møller-Jensen J. Escherichia coli uropathogensis in vitro: invasion, cellular escape, and secondary infection analyzed in a human bladder cell infection model. Infect Immun 2012; 80: 1858-67.
26. Langermann S, Palaszynski S, Barnhart M,. et al. Prevention of mucosal Escherichia coli infection by FimH-Adhesin-based systemic vaccination. Science 1997; 276: 607-11.
27. Andersen TE, Kingshott P, Palarasah Y, Benter M, Alei M, Kolmos HJ. A flow chamber assay for quantitative evaluation of bacterial surface colonization used to investigate the influence of temperature and surface hydrophilicity on the biofilm forming capacity of uropathogenic Escherichia coli. J Microbiol Methods 2010; 81: 135-40.
28. Mobley HL, Green DM, Trifillis AL,. et al. Pyelonephritogenic Escherichia coli and killing of cultured human renal proximal tubular epithelial cells: role of hemolysin in some strains. Infect Immun 1990; 58: 1281-9.
29. Berry RE, Klumpp DJ, Schaeffer AJ. Urothelial cultures support intracellular bacterial community formation by uropathogenic Escherichia coli. Infect immun 2009; 77: 2762-72.
30. Klein K, Palarasah Y, Kolmos HJ, Møller-Jensen J, Andersen TE. Quantification of filamentation by uropathogenic Escherichia coli during experimental bladder cell infection by using semi-Automated image analysis. J Microbiol Methods 2015; 109: 110-6.
31. Korhornen T. Yeast cell agglutination by purified enterobacterial pili. FEMS Microbiol Lett 1979; 6: 421-5.
32. Krogfelt KA, Klemm P. Investigation of minor components of Escherichia coli type 1 fimbriae: protein chemical and immunological aspects. Microb Pathog 1988; 4: 231-8.
33. Iida K, Mizunoe Y, Wai SN, Yoshida S. Type 1 fimbriation and its phase switching in diarrheagenic Escherichia coli strain. Clin Diagn Lab Immunol 2001; 8: 489-95.
34. Wu XR, Sun TT, Medina JJ. In vitro binding of type 1-fimbriated Escherichia coli to uroplakins Ia and Ib: relation to urinary tract infections. Proc Natl Acad Sci U S A 1996; 93: 9630-5.
35. Schwan WR, Lee JL, Lenard FA, Matthews BT, Beck MT. Osmolarity and pH growth conditions regulate fim gene transcription and type 1 pilus expression in uropathogenic Escherichia coli. Infect Immun 2002; 70: 1391-402.
36. Parfentjev I, Perlzweig W. The composition of the urine of white mice. J Biol Chem 1932; 100: 551-5.
37. Trautner BW, Cevallos ME, Huaiguang L,. et al. Increased expression of type-1 fimbriae by nonpathogenic Escherichia coli 83972 results in an increased capacity for catheter adherence and bacterial interference. J Infect Dis 2008; 198: 899-906.
38. Bahrani-Mougeot FK, Buckles EL, Lockatell CV,. et al. Type 1 fimbriae and extracellular polysaccharides are preeminent uropathogenic Escherichia coli virulence determinants in the murine urinary tract. Mol Microbiol 2002; 45: 1079-93.
39. Martinez JJ, Mulvey MA, Schilling JD, Pinker JS, Hultgren SJ. Type 1 pilus-mediated bacterial invasion of bladder epithelial cells. EMBO J 2000; 19: 2803-12.
40. Hunstad DA, Justice SS. Intracellular lifestyles and immune evasion strategies of uropathogencis Escherichia coli. Annu Rev Microbiol 2010; 64: 203-21.
41. Ofek I, Mosek A, Sharon N. Mannose-specifik adherence of Escherichia coli freshly excreted in the urine of patients with urinary tract infections, and of isolates subcultured from the infected urine. Infect Immun 1981; 34: 708-11.
42. Harber MJ, Chick S, Mackenzie R, Asscher AW. Lack of adherence to epithelial cells by freshly isolated urinary pathogens. Lancet 1982; 1: 586-8.
43. Snyder JA, Haugen BJ, Buckles EL,. et al. Transcriptome of uropathogenic Escherichia coli during urinary tract infection. Infect Immun 2004; 72: 6373-81.
44. Bergsten G, Wullt B, Schembri MA, Leijonhufvud I, Svanborg C. Do type 1 fimbriae promote inflammation in the human urinary tract?. Cell Microbiol 2007; 9: 1766-81.
45. Carey AJ, Tan CK, Ipe DS,. et al. Urinary tract infection of mice to model human disease: practicalities, implications and limitations. Crit Rev Microbiol 2015; 26: 1-20.
46. Subashchandrabose S, Hazen TH, Brumbaugh AR,. et al. Host-specific induction of Escherichia coli fitness genes during human urinary tract infections. Proc Natl Acad Sci U S A 2014; 111: 18327-32.
47. Delnay KM, Stonehill WH, Goldman H, Jukkola AF, Dmochowski RR. Bladder histological changes associated with chronic indwelling urinary catheter. J Urol 1999; 161: 1106-9.
48. Ipe DS, Sundac L, Benjamin WH Jr, Moore KH, Ulett GC. Asymptomatic bacteriuria: prevalence rates of causal microorganisms, etiology of infection in different patient populations, and recent advances in molecular detection. FEMS Microbiol Lett 2013; 346: 1-10.
49. Hedlund M, Frendéus B, Wachtler C, Hang L, Fischer H, Svanborg C. Type 1 fimbriae deliver an LPS- and TLR4-dependent activation signal to CD14-negative cells. Mol Microbiol 2001; 39: 542-52.
50. Mossman KL, Mian MF, Lauzon NM,. et al. Cutting edge: FimH adhesin of type 1 fimbriae is a novel TLR4 ligand. J Immunol 2008; 181: 6702-6.
51. Schilling JD, Mulvey MA, Hultgren SJ. Dynamic interactions between host and pathogen during acute urinary tract infections. Urology 2001; 57: 56-61.
52. Miyazaki J, Ba-TheinW, Kumao T, YasuakaMO, Akaza H, Hayshi H. Type 1, P and S fimbriae, and afimbrial adhesin I are not essential for uropathogenic Escherichia coli to adhere to and invade bladder epithelial cells. FEMS Immunol MedMic 2002; 33: 23-6.